J Korean Med Sci.  2008 Oct;23(5):838-844. 10.3346/jkms.2008.23.5.838.

Human Leukocyte Antigen Class II Association with Spontaneous Recovery from Hepatitis B Virus Infection in Koreans: Analysis at the Haplotype Level

• Cho SW
• Cheong JY
• Ju YS
• Oh DH
• Suh YJ
• Lee KW

• KMID: 1783070
• DOI: http://doi.org/10.3346/jkms.2008.23.5.838

Abstract

It has been speculated that human leukocyte antigen (HLA) alleles are associated with the outcome of hepatitis B virus (HBV) infection although the data obtained from various populations have shown some inconsistencies. A total of 464 HBVinfected Korean individuals (80 spontaneously recovered [SR] and 384 chronically infected [CI]) were selected to investigate the association of HLA class II alleles with the viral clearance and persistence. Our results showed that: 1) multiple HLA class II alleles and haplotypes were associated with viral clearance (DRB1*1302, DRB1*1502, DQB1*0302, DQB1*0609, and related-haplotypes) and persistence (DRB1*0701, DQB1*0301, and related-haplotypes); 2) DRB1*1302 and DQB1* 0609 were more strongly associated with viral clearance. And the association of DQB1*0609 (pc=0.0084; OR, 7.24) with vial clearance was much stronger than previously recognized, DRB1*1302 (pc=0.0038; OR, 4.34); and 3) linkage to a specific DPB1 allele in a haplotype strengthened the association with viral clearance, although DPB1 itself was not associated with the outcome. These results indicate the existence of multiple factors controlling viral clearance in the HLA class II gene region. Further extended investigation on the genetic factors related to the outcome of HBV infection will provide valuable insights into the understanding of the mechanisms involved.

Keyword

Hepatitis B Virus; Clearance; Persistence; DQB1*0609; DRB1*1302

MeSH Terms

Alleles
*Genes, MHC Class II
HLA Antigens/*genetics
HLA-DQ Antigens/*genetics
HLA-DR Antigens/*genetics
*Haplotypes
Hepatitis B/*immunology/*virology
Hepatitis B virus/genetics
Humans
Immunophenotyping
Korea
Models, Genetic
Remission Induction
Treatment Outcome

Reference

1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997. 337:1733–1745.

2. Iino S. Natural history of hepatitis B and C virus infections. Oncology. 2002. 62:Suppl 1. 18–23.

3. Lok AS, McMahon BJ; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B. Hepatology. 2001. 34:1225–1241.

4. Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis. 2002. 2:43–50.

5. Urbani S, Boni C, Amadei B, Fisicaro P, Cerioni S, Valli MA, Missale G, Ferrari C. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection. Hepatology. 2005. 41:826–831.

6. Davenport MP, Quinn CL, Chicz RM, Green BN, Willis AC, Lane WS, Bell JI, Hill AV. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain. Proc Natl Acad Sci USA. 1995. 92:6567–6571.

7. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci. 2002. 17:457–462.

8. Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, Kim YS, Park K, Kim DK, Moon YM. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology. 2000. 31:1371–1373.

9. Hwang SH, Sohn YH, Oh HB, Hwang CY, Lee SH, Shin ES, Lee KJ. Human leukocyte antigen alleles and haplotypes associated with chronicity of hepatitis B virus infection in Koreans. Arch Pathol Lab Med. 2007. 131:117–121.

10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988. 16:1215.

11. Kotsch K, Wehling J, Blasczyk R. Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: Sequencing based typing of HLA-DRB genes. Tissue Antigens. 1999. 53:486–497.

12. Van der Zwan A, Griffith B, Rozemuller E, Williams T, Tilanus MG. Tilanus MGJ, Hansen JA, Hurley CK, editors. Sequence-based typing for HLA-DQB1 strategy for ABI sequencing equipment. IHWG Technical Manual. 2000. Seattle: International Histocompatibility Working Group;TM12A1–TM12A4.

13. Van der Zwan A, Rozemuller E, Tilanus MG. Tilanus MGJ, Hansen JA, Hurley CK, editors. Sequence-based typing for HLA-DPB1 strategy for ABI equipment. IHWG Technical Manual. 2000. Seattle: International Histocompatibility Working Group;TM14A1–TM14A4.

14. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001. 68:978–989.

15. Lee KW, Oh DH, Lee C, Yang SY. Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens. 2005. 65:437–447.

16. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med. 1995. 332:1065–1069.

17. Höhler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, Löhr HF, Schneider PM, Meyer zum Büschenfelde KH, Rittner C. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol. 1997. 26:503–507.

18. Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol. 2003. 77:12083–12087.

19. Diepolder HM, Jung MC, Keller E, Schraut W, Gerlach JT, Grüner N, Zachoval R, Hoffmann RM, Schirren CA, Scholz S, Pape GR. A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol. 1998. 113:244–251.

20. Cao T, Desombere I, Vanlandschoot P, Sallberg M, Leroux-Roels G. Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B. J Gen Virol. 2002. 83:3023–3033.

21. Van Hattum J, Schreuder GM, Schalm S. HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology. 1987. 7:11–14.

22. Begovich AB. HLA-DPA1, -DPB1, DQA1, and -DQB1 allele frequencies in a population from Gambia. Hum Immunol. 2004. 65:944–945.

23. Thio CL, Carrington M, Marti D, O'Brien SJ, Vlahov D, Nelson KE, Astemborski J, Thomas DL. Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis. 1999. 179:1004–1006.

24. Jiang YG, Wang YM, Liu TH, Liu J. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J Gastroenterol. 2003. 9:2221–2225.

25. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet. 1994. 344:1194–1195.

26. Yang G, Liu J, Han S, Xie H, Du R, Yan Y, Xu D, Fan D. Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China. Tissue Antigens. 2007. 69:170–175.

27. Milner CM, Campbell D, Trowsdale J. Lechler R, Warrens A, editors. Molecular genetics of the human major histocompatibility complex. HLA in health and disease. 2000. London: Academic press;35–50.